Radspherin for ovarian cancer with peritoneal spread
Part of Cancer, Digestive system, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests a radioactive treatment called Radspherin given during surgery for advanced ovarian cancer that has spread to the lining of the abdomen. It is for people whose tumors are HR proficient (a specific genetic type) and who have already had chemotherapy before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and a woman.
- You have advanced high-grade serous or endometrioid ovarian, fallopian tube, or primary peritoneal cancer (stage IIIB/C or IV).
- Your cancer has spread to the lining of the abdomen (peritoneum) but can be completely removed during surgery.
- Your tumor is HR proficient (a lab test shows it does not have certain genetic changes).
- You have already received chemotherapy (neoadjuvant) and your tumor has not grown.
- You are healthy enough for surgery and further treatment (ECOG score 0–2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called IMNN-001 combined with standard chemotherapy for women with advanced ovarian, fallopian tube, or peritoneal cancer. The goal is to see if adding this drug can improve safety and effectiveness.
This trial tests a new medication (HS-20089) for people with ovarian or endometrial cancer that has come back or spread. It aims to see if the drug can shrink tumors or slow cancer growth.
This trial checks whether having surgery to remove as much tumor as possible, followed by ongoing targeted treatment, helps people with advanced ovarian (and related) cancers live longer and/or control cancer better. It specifically uses tumor-testing results to match patients and then continues treatment after surgery.
This trial checks if adjusting the timing of surgery (interval debulking surgery) after chemotherapy can improve outcomes for people with advanced ovarian cancer. It's for those who cannot have surgery right away and will receive chemotherapy first.
This Phase 1 study tests a new way to deliver chemotherapy inside the abdomen (belly) using a pressurized aerosol during a procedure, along with standard blood (IV) chemotherapy. It may help people with advanced ovarian cancer whose tumors have not progressed but are not removable with surgery yet.
This trial tests a new type of radiation therapy guided by MRI scans to treat small areas of cancer that have spread to the lining of your abdomen. It may offer better targeting and fewer side effects than standard radiation.
Hear when a new Peritoneal Carcinomatosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.